Investigational device has the potential to transform a half-century-old standard of care BOSTON, Feb. 10, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, has treated the first patient in a study of its eShunt System, an investigational device intended to treat communicating […]
Neuro
RapidAI Cleared in Argentina and Adopted by Top Hospitals to Improve Stroke Imaging and Care
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced imaging for stroke, today announced it has received registration approval and clearance from Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) for the Rapid imaging platform. Rapid is available to hospitals across Argentina, and already in use at Clínica La […]
Medtronic Announces Early Site Release of New Radial Artery Access Portfolio Following First-in-Patient Procedure
Acquisition of RIST Neurovascular Enhances Medtronic’s Capabilities to Serve Patients Treated for Brain Aneurysms and Other Neurovascular Conditions DUBLIN, Feb. 1, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced expansion of its limited site release of the recently acquired radial artery access portfolio from privately-held RIST Neurovascular, […]
Biomodex Teams Up with Physicians at Three of the World’s Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic Stroke
Lifelike tool enables neurointerventionalists to simulate fluoroscopy-guided procedures and validate success removing blockages from different artery access points in a variety of anatomies BOSTON, Feb. 1, 2021 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered […]
RapidAI Enhancing Stroke Care Across Australia
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced imaging for stroke, today announced it now serves over 50 hospitals and teleradiology services in Australia. The Rapid stroke imaging platform is TGA cleared. Rapid is the first AI-powered stroke imaging solution approved in Australia. Around the world, Rapid is also the […]
Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China
– Partnership to be in tandem with formation of Genesis Medtech’s Neurovascular Franchise, pending an ongoing full acquisition of Hua Medtech – The collaboration will position Genesis MedTech (“Genesis”) as the largest local company in China’s neurovascular space SINGAPORE, Jan. 19, 2021 /PRNewswire/ — Genesis MedTech Group has reached a consensus to […]
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders […]
Rapid Medical Receives FDA Clearance for the World’s First Steerable Neurovascular Guidewire
DRIVEWIRE™ provides efficient access in difficult neuro and peripheral vascular procedures YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces the FDA clearance of DRIVEWIRE, a novel guidewire with a steerable distal tip that handles complex anatomical […]
Cerus Endovascular Announces the First Ever Robotic Assist Intracranial Implant of its Contour Intrasaccular Device
Groundbreaking Aneurysm Procedure Completed in 28 Minutes FREMONT, Calif. and OXFORD, United Kingdom, Dec. 17, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced the first ever robotically assisted intracranial implant of its Contour intrasaccular device. The groundbreaking procedure was completed at the King Edward Memorial Hospital, Mumbai, by renowned neurosurgeon, Dr. Nitin Dange and […]
First Patients Enrolled in Balt STEM Trial
IRVINE, Calif.–(BUSINESS WIRE)–Balt announced today that the first patients have been enrolled in the clinical trial; The SquidTM Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic subdural hematoma [NCT04410146]. This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for […]



